Skip to main content
. 2021 Nov 5;3(12):e855–e864. doi: 10.1016/S2665-9913(21)00316-7

Table 2.

Outcomes according to the ordinal COVID-19 severity scale by type of disease

All patients (n=1020) Giant cell arteritis (n=158) ANCA-associated vasculitis (n=294) Polymyalgia rheumatica (n=323) Behçet's syndrome (n=97) Other vasculitis (n=148)
Not hospitalised 512 (50·2%) 69 (43·7%) 110 (37·4%) 187 (57·9%) 69 (71·1%) 77 (52·0%)
Hospitalisation with no supplemental oxygen 114 (11·2%) 19 (12·0%) 30 (10·2%) 30 (9·3%) 15 (15·5%) 20 (13·5%)
Hospitalisation with ventilation or supplemental oxygen 239 (23·4%) 38 (24·1%) 89 (30·3%) 71 (22·0%) 11 (11·3%) 30 (20·3%)
Death 155 (15·2%) 32 (20·3%) 65 (22·1%) 35 (10·8%) 2 (2·1%) 21 (14·2%)

Data are n (%). This analysis excludes 182 patients with missing outcome data. ANCA=antineutrophil cytoplasmic antibody.